Navigation Links
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
Date:11/7/2013

third quarter and first nine months of 2012, respectively.

Net loss in the third quarter of 2013 was $16.5 million or $0.14 per share as compared to a net loss of $43.5 million or $0.38 per share in the third quarter of 2012. Net loss in the first nine months of 2013 was $114.4 million or $0.99 per share as compared to a net loss of $118.9 million or $1.04 per share in the first nine months of 2012.

Conference Call to Discuss Third Quarter 2013 Financial ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time today, Thursday, November 7, 2013.

This press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Monday, December 9, 2013. To access the conference call, follow these instructions: Dial: (877) 881.2183 (U.S.); (970) 315.0453 (international)Passcode: 91919000 (Nektar Therapeutics is the host)In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics (NASDAQ: NKTR) is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in pain, oncology and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
8. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
9. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
10. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
11. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... NUEVA YORK , 22 de mayo ... (NASDAQ: DPRX ), una compañía farmacéutica ... y comercialización de Locilex® (pexiganan cream 0.8%), ... hoy una presentación de póster destacando el ... fase 3 de la Compañía que evalúan ...
(Date:5/22/2015)... May 22, 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ... grade hypothermic storage and cryopreservation freeze ... and tissues ("BioLife" or the "Company"), announced that the Company ... The Company is scheduled to present at ... 2015 at the Grand Hyatt Hotel in New ...
(Date:5/22/2015)... The leading companies in the cardiac ... rhythm management device market dominate their competition, according ... Jude Medical, Boston Scientific and Asahi Kasei (with ... The healthcare market research publisher,s report, Cardiac ... a base year, providing forecasts for each year ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
(Date:5/23/2015)... With the implementation of the Affordable ... increasingly difficult to provide their employees with a viable ... insurance for employees stand to face strict penalties. Never ... part of a business’s success or failure. In an ... USA Doctors has created a varying level of less ...
(Date:5/23/2015)... May 23, 2015 Manufacturers are now required ... Factor (HSPF) of 8.2. Experts in the field agree that ... consumers. , The HSPF score is what miles per gallon ... efficient the unit. Although the minimum HSPF score has been ... with an HSPF score north of 12. Indeed, the regulation ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... OR (PRWEB) May 22, 2015 Pioneer ... remains at the forefront of designing with reclaimed wood, ... Design in Los Angeles, California. Their newest offerings, Vat ... bring much-anticipated surface and color to America's largest design ... our exhibit at each show, anxious to see and ...
Breaking Medicine News(10 mins):Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... of Body By Milk MVP, DANBURY, N.C., Oct. ... nature to the superstar athletes at North Stokes High ... that the,Tigers Varsity football team has earned the title ... was nominated to be part of the,first-ever nationwide Refuel ...
... Isolagen(TM), Inc. (Amex:,ILE) announced today that all injections ... investigating Isolagen Therapy(TM) for the treatment,of moderate to ... all,of the study participants have completed the final ... in the first quarter of,2009., "The second ...
... TrekDesk is a workstation that fits over an existing treadmill and allows ... , ... Phoenix, AZ (Vocus) October 21, 2008 -- Wouldn,t it be wonderful ... improve their health, ward off disease, shed excess weight and make them ...
... Improves Patient Recruitment Process, SAN FRANCISCO, ... of software solutions to optimize clinical trial ... availability of StudyOptimizer,4.0, the latest version of ... patient recruitment process in clinical trials, the ...
... parents with ... disabilities, ... Disabilities and their Families has been established in,Berkeley, California under the ... The Center will oversee several,national research studies concerning parents with disabilities ...
... Remains for Agents that are Effective in,Treating Triple-Negative ... Resources, WALTHAM, Mass., Oct. 21 Decision ... firms for pharmaceutical and,healthcare issues, finds that significant ... over 20 percent of total,sales in the breast ...
Cached Medicine News:Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 2Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 3Health News:Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study 2Health News:Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study 3Health News:Help Employees Boost Memory, Lose Weight, Get Healthier & Increase Productivity 2Health News:DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0 2Health News:DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0 3Health News:New National Center for Parents with Disabilities and their Families 2Health News:New National Center for Parents with Disabilities and their Families 3Health News:Genentech/Roche/Chugai's Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017 2
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
Designed to lift corneal cap/flap during corneal lamellar surgery...
Pre-expanded for convenience; no need to pre-soak and fan. Lint-free PVAmaterial...
Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
Medicine Products: